05/14/2026
GLP-1 medications can be a meaningful part of a medically supervised weight management plan. But a prescription alone is rarely the whole answer.
One of the most commonly overlooked issues with GLP-1 therapy is lean mass loss. When the body is in a significant caloric deficit, it doesn't only draw from fat stores — muscle tissue is at risk too. Preserving lean mass matters not just for aesthetics, but for metabolic rate, insulin sensitivity, and long-term weight maintenance.
This is where a broader protocol becomes important. Peptides like Tesamorelin — a growth hormone-releasing hormone analogue — may support body composition by helping preserve lean tissue during periods of caloric restriction, when clinically appropriate and provider-guided. Lab monitoring, including IGF-1 levels, is part of responsible use.
GI tolerance is another real challenge. Many patients experience nausea, reduced appetite, or GI discomfort, particularly early in GLP-1 therapy. Addressing these side effects through clinical support — rather than simply stopping the medication — can make a meaningful difference in adherence and outcomes.
Protein intake and resistance training remain foundational. No medication replaces the role of adequate dietary protein and consistent strength work in protecting muscle during weight loss.
At The Tide, we approach GLP-1 therapy as one component of a broader metabolic plan — not a standalone solution. That means labs before prescribing, regular follow-up, and a protocol designed around the individual patient.
Treatment eligibility depends on clinical evaluation. This content is educational and not medical advice.